We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us


Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App

Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology

By LabMedica International staff writers
Posted on 02 Aug 2018
Print article
Image: The XW-100 CBC analyzer (Photo courtesy of Sysmex).
Image: The XW-100 CBC analyzer (Photo courtesy of Sysmex).
Sysmex (Kobe, Japan) celebrated its 50th anniversary at this year’s annual meeting of the American Association for Clinical Chemistry (AACC) and shared its plans to equip the clinical laboratory of the future with innovative solutions in flow cytometry, urinalysis and hematology. The AACC 2018 held July 29 – August 2 in Chicago, Illinois, USA, was attended by approximately 20,000 clinical laboratory professionals from more than 110 countries.

Sysmex offers clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. The company is innovating across all of its diagnostic practices, including flow cytometry, urinalysis and hematology.

At AACC 2018, Sysmex showcased its first fully automated urine particle analyzer, which reduces the need for manual slide review and delivers first-pass accuracy and unprecedented workflow efficiency. Sysmex’s UN series consists of three analyzer modules and is the first fully configurable urinalysis solution to offer expanded parameters. In addition to being configurable to meet the needs of every laboratory, Sysmex’s solution will allow laboratorians to focus more time on analyzing test results.

Visitors to the Sysmex booth were able to view the company’s new comprehensive flow cytometry system which is highly automated and features a broad portfolio of CyFlow anti-body reagents and the PS-10 sample preparation system with automated cell wash. The new product also includes the XF-1600 flow cytometer with multi-colored capability, high sample throughput and software solutions for the most difficult samples. Sysmex also displayed its FDA-cleared XN-20 complete blood count (CBC) analyzer, a complementary system to its XN-10.

Also on display at Sysmex’s booth at AACC was the automated GloCyte cell counter system, which provides an unprecedented detection level for automated cerebrospinal fluid (CSF) cell counts. Sysmex also showcased its first-of-its-kind XW-100, the world’s first CLIA-waived CBC analyzer that can provide three-part blood test results in as few as three minutes, allowing patients to get answers faster and their physicians to develop treatment plans more quickly.

“As we celebrate five decades of providing laboratories around the world with highly accurate, efficient and dependable diagnostic solutions, we are excited about what we have in store for the laboratory of the future,” said Ralph Taylor, chief executive officer of Sysmex America. “The path to better healthcare is through better testing and Sysmex is lighting the way.”

“Laboratories are facing growing staffing and reimbursement challenges,” said Andy Hay, chief operating officer of Sysmex America. “Sysmex is developing innovative solutions that increase efficiency and allow clinical laboratory professionals to do the work that both ignites their passion for diagnostics and leads to the greatest impact on patient care.”

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.